International Conference on Cancer Biology and Molecular Oncology (ICCBMO - 26)

This session will explore the intricate molecular pathways involved in tumorigenesis, focusing on the roles of oncogenes and tumor suppressor genes. Discussions will include recent advancements in understanding the genetic and epigenetic alterations that drive cancer development.

This track will delve into the complex signaling networks that regulate cell proliferation and apoptosis in cancer. Participants will examine how dysregulation of these pathways contributes to tumor growth and metastasis.

This session will highlight the latest innovations in targeted therapies aimed at specific molecular targets in cancer cells. Emphasis will be placed on the mechanisms of action, efficacy, and resistance associated with these therapeutic approaches.

This track will focus on the integration of genomic and epigenetic data to understand cancer biology. Researchers will present findings on how these layers of regulation influence tumor behavior and patient outcomes.

This session will investigate the interactions between tumor cells and their microenvironment, with a particular focus on angiogenesis. Discussions will include how these interactions facilitate cancer progression and therapeutic resistance.

This track will explore the role of cancer stem cells in tumor initiation and metastasis. Researchers will discuss the unique properties of these cells and their implications for treatment strategies.

This session will cover the advancements in molecular diagnostics that enhance cancer detection and monitoring. Topics will include the development of biomarkers and their clinical applications in personalized medicine.

This track will examine the biological mechanisms underlying chemotherapy resistance in cancer treatment. Researchers will present novel strategies to overcome resistance and improve therapeutic efficacy.

This session will focus on the immune system's role in cancer biology and the development of immunotherapeutic strategies. Topics will include immune checkpoint inhibitors, CAR T-cell therapy, and the tumor immune microenvironment.

This track will highlight the latest research in biomarker discovery for cancer diagnosis and prognosis. Emphasis will be placed on translating these findings into clinical practice to improve patient outcomes.

This session will explore the dynamic processes of cancer progression and the development of innovative therapeutic strategies. Discussions will include the integration of multi-omics approaches to understand and combat cancer.